Questions discussed in this category
How often are you scanning the brain and what is your trigger to treat?
If so, what percent likelihood do you quote patients for this risk with SRS, SRT and fully fractionated therapy?
Do you routinely discontinue the device or continue if they are otherwise tolerating the treatment well?
What is the diagnostic yield and complication rate in your experience?
NCCN lists PCV as category 1 (and now with analysis in Abstract 2002 from ASCO 2019 showing benefit in IDH mutated), and temozolomide as 2B, yet temoz...
For medical oncologists, would you offer a PD-1/L1 inhibitor? For other subspecialties, how would you counsel the oncologist regarding the risk of usi...
What would be your preferred technique and dose/fractionation?
For stroke-like migraine attacks after radiation therapy (SMART syndrome), does your management of these patient's change with recurrent episodes? How...
Can intrathecal methotrexate be continued with close neurologic observation vs switch in treatment now due to findings?
If so, when do you consider this?
Do you biopsy immediately, stop treatment, biopsy at a later time, or depend solely on the data you already have?
Is there any additional benefit to radiation in addition to steroids in a patient who is not a surgical candidate?
Has the recently published interim analysis of the CATNON trial altered your utilization of temozolomide?
Does IDH status change your treatment appro...
Do you consider the small, but statistically significant, improvement in OS to outweigh the side effects of treatment?
What workup do you typically recommend?
Length of temozolomide course when given with adjuvant radiotherapy
What factors play into your decision whether to re-treat the brain with craniospinal radiotherapy vs irradiation of the spine only vs other measures (...
E.g. The case in question is for a patient planned for thoracic RT for LS-SCLC. Any medications that may help or just give much bigger expansions to c...
When do you favor RT? What is your preferred dose/fractionation?
How does length of time from prior chemoradiotherapy influence your management?
In a palliative setting, how long would you wait to initiate WBRT?
129741282883741191212524124671190553261186311620115281028911389131611379109481101682521039010381103171052981959299101339796953773389498633
Papers discussed in this category
Stroke, 2008 Jul 17
J Neuroimaging, 2020 Feb 10
The New England journal of medicine, 2014-02-20
The New England journal of medicine, 2014-02-20
Neuro-oncology, 2016-09
Onco Targets Ther, 2017 Jan 18
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-01-20
The New England journal of medicine, 2005-03-10
The New England journal of medicine, 2016-04-07
J Clin Oncol, 2012 Oct 15
J Clin Oncol,
Neuro Oncol, 2016 Jul 01
Pediatric emergency care, 2008-04
Clin Nucl Med,
World J Surg Oncol, 2019 Mar 27
Asian J Neurosurg,
Journal of neurosurgery, 2005-09
Surgical neurology, 2000-05
Cureus, 2020 Jun 11
Stereotact Funct Neurosurg, 2019 Nov 26
N Engl J Med,
Acta Oncol, 2015 Oct 23
Int J Radiat Oncol Biol Phys, 2020 Jun 13
Neuro-oncology, 2013-10
Acta Neurochir (Wien), 2019 Jan 29
J. Clin. Oncol., 2020 Feb 14
Cancer, 2020 May 19
N Engl J Med,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-09-01
Lancet Oncol, 2021 May 14
Strahlenther Onkol,
International journal of radiation oncology, biology, physics, 2018-06-01
Surgical neurology international, 2018
J Neurooncol, 2019 Oct 01
Progress in neurological surgery, 2013
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993-03
Neurosurgery,
Cancer, 2011 Feb 01
JAMA, 2017-12-19
J Clin Oncol, 2021 Dec 13
The New England journal of medicine, 2018-08-23
Lancet Oncol, 2020 Apr 03